NAGEZE Joint Pain

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

Terminalia chebula, Quantity: 200 mg (Equivalent: Chebulinic and chebulagic acid, Qty 40 mg; Equivalent: Terminalia chebula, Qty 1000 mg); Curcuma longa, Quantity: 100 mg (Equivalent: curcuminoids (of Curcuma longa), Qty 44.6 mg; Equivalent: Curcuma longa, Qty 2000 mg)

Verfügbar ab:

Substance Pty Ltd

Darreichungsform:

Capsule, hard

Zusammensetzung:

Excipient Ingredients: silicon dioxide; microcrystalline cellulose; magnesium stearate; hypromellose; betadex

Verabreichungsweg:

Oral

Anwendungsgebiete:

Antioxidant/Reduce free radicals formed in the body ; Helps enhance/promote general health and wellbeing ; Traditionally used in Ayurvedic medicine to Anti-inflammatory/relieve inflammation ; Traditionally used in Ayurvedic medicine to Analgesic/Anodyne/relieve pain ; Traditionally used in Ayurvedic medicine to Decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; Traditionally used in Ayurvedic medicine to Decrease/reduce/relieve mild joint inflammation/swelling ; Traditionally used in Ayurvedic medicine to Maintain/support healthy digestive system function ; Traditionally used in Ayurvedic medicine to Maintain/support healthy digestion

Produktbesonderheiten:

Visual Identification: ;

Berechtigungsstatus:

Listed

Berechtigungsdatum:

2018-10-16